Zhao, S.; Agyare, E.; Zhu, X.; Trevino, J.; Rogers, S.; Velazquez-Villarreal, E.; Brant, J.; Eliahoo, P.; Barajas, J.; Hoang, B.X.;
et al. ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. Cancers 2025, 17, 870.
https://doi.org/10.3390/cancers17050870
AMA Style
Zhao S, Agyare E, Zhu X, Trevino J, Rogers S, Velazquez-Villarreal E, Brant J, Eliahoo P, Barajas J, Hoang BX,
et al. ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. Cancers. 2025; 17(5):870.
https://doi.org/10.3390/cancers17050870
Chicago/Turabian Style
Zhao, Shuqing, Edward Agyare, Xueyou Zhu, Jose Trevino, Sherise Rogers, Enrique Velazquez-Villarreal, Jason Brant, Payam Eliahoo, Jonathan Barajas, Ba Xuan Hoang,
and et al. 2025. "ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer" Cancers 17, no. 5: 870.
https://doi.org/10.3390/cancers17050870
APA Style
Zhao, S., Agyare, E., Zhu, X., Trevino, J., Rogers, S., Velazquez-Villarreal, E., Brant, J., Eliahoo, P., Barajas, J., Hoang, B. X., & Han, B.
(2025). ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. Cancers, 17(5), 870.
https://doi.org/10.3390/cancers17050870
